Get the Stockscreener App
346.00
0.44%
1.50
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $346.00, with a volume of 1.61M.
It is up +0.44% in the last 24 hours and down -4.79% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$344.50
Open:
$345
24h Volume:
1.61M
Relative Volume:
1.06
Market Cap:
$67.12B
Revenue:
$321.33B
Net Income/Loss:
$1.57B
P/E Ratio:
43.51
EPS:
7.9518
Net Cash Flow:
$3.21B
1W Performance:
+1.87%
1M Performance:
-4.79%
6M Performance:
+17.27%
1Y Performance:
+49.06%
1-Day Range:
$342.40
$347.83
1-Week Range:
$335.84
$347.83
52-Week Range:
$223.92
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
346.00 | 66.83B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
813.80 | 100.66B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
198.18 | 47.12B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
76.55 | 8.98B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.35 | 744.44M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
BI Asset Management Fondsmaeglerselskab A S Grows Stock Position in Cencora, Inc. $COR - MarketBeat
Bellevue Group AG Trims Holdings in Cencora, Inc. $COR - MarketBeat
How Low Can Cencora Stock Really Go? - Trefis
Earnings Recap: How strong dollar benefits Ares Commercial Real Estate Corporation 41I stockPortfolio Gains Summary & Long Hold Capital Preservation Tips - moha.gov.vn
Cencora Makes Major Bet on Global Pharma Logistics With U.S.–Europe Expansion - MyChesCo
Cencora’s Expanded Cold Chain and 3PL Network Might Change The Case For Investing In Cencora (COR) - Yahoo Finance
Cencora, Inc. $COR Shares Purchased by CIBC Asset Management Inc - MarketBeat
Farminveste's unit Alliance Healthcare sells to Cencora all of shares it held in Alloga Logifarma - marketscreener.com
The Manufacturers Life Insurance Company Raises Stock Holdings in Cencora, Inc. $COR - MarketBeat
Here's Why You Should Add Cencora Stock to Your Portfolio Now - Finviz
Investment Management Corp of Ontario Reduces Stake in Cencora, Inc. $COR - MarketBeat
iSAM Funds UK Ltd Takes Position in Cencora, Inc. $COR - MarketBeat
State Street Corp Sells 6,729 Shares of Cencora, Inc. $COR - MarketBeat
Natixis Has $8.34 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
L2 Asset Management LLC Sells 15,893 Shares of Cencora, Inc. $COR - MarketBeat
JPMorgan raises Cencora (COR) price target after financial model update - MSN
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
How Is Cencora’s Stock Performance Compared to Other Medical Stocks? - MSN
Lombard Odier Asset Management USA Corp Invests $3.16 Million in Cencora, Inc. $COR - MarketBeat
Gabelli Funds LLC Reduces Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Stock Holdings Boosted by Axa S.A. - MarketBeat
Cencora initiated with an Overweight at Barclays - TipRanks
Walleye Capital LLC Boosts Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by California Public Employees Retirement System - MarketBeat
Will Cencora Inc stock beat revenue estimatesQuarterly Trade Review & Weekly Setup with ROI Potential - moha.gov.vn
Cencora Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Federated Hermes Inc. Increases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Burgundy Asset Management Ltd. Sells 157,024 Shares of Cencora, Inc. $COR - MarketBeat
With Cencora Stock Sliding, Have You Assessed The Risk? - Trefis
Marshall Wace LLP Has $96.66 Million Holdings in Cencora, Inc. $COR - MarketBeat
Would You Still Hold Cencora Stock If It Fell Another 30%? - Trefis
Cencora's Healthcare Bio Logistics Strategy - Healthcare Digital
Amundi Has $500.89 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? - sharewise.com
Cencora Sees Unusually High Options Volume (NYSE:COR) - MarketBeat
Iterum Therapeutics Provides Business Update - GlobeNewswire Inc.
Why Cencora Inc. stock appears on watchlistsJuly 2025 Trends & Risk Controlled Daily Trade Plans - Newser
Cencora, Inc. $COR Shares Sold by First Trust Advisors LP - MarketBeat
Beutel Goodman & Co Ltd. Sells 177,824 Shares of Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock could break out in 20252025 Pullback Review & Real-Time Stock Price Movement Reports - Newser
Why Cencora Inc. stock is in analyst buy zoneJuly 2025 Reactions & High Yield Stock Recommendations - Newser
How rising interest rates impact Cencora Inc. stockPortfolio Return Report & AI Powered Market Entry Ideas - Newser
Cencora, Inc. (NYSE:COR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is Cencora Inc. (ABG) stock supported by strong fundamentalsJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
Is Cencora (COR) Quietly Rewriting Its Moat With an Aggressive Bet on Cryogenic Logistics? - simplywall.st
Cencora (NYSE:COR) Stock Price Down 4.6%Should You Sell? - MarketBeat
How Cencora Inc. stock compares with market leadersTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will Cencora Inc. (ABG) stock attract long term capital inflowsJuly 2025 Final Week & Reliable Momentum Entry Alerts - Newser
Can Cencora Inc. stock deliver consistent earnings growth2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - Newser
Cencora Inc. Stock Slips 4.4%, Underperforms Peers - 富途牛牛
Why Cencora Inc. (ABG) stock stays on top picks2025 Market Overview & Weekly Market Pulse Updates - Newser
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):